Innealta Capital’s Transmedics TMDX Stock Holding History

Innealta Capital’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16	Closed	-$2.41K	–	1535
2024 Q2	$2.41K	Buy	+16	New	+$1.92K	﹤0.01%	1036

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Innealta Capital's TMDX Position: Q3 2024 in Review

Innealta Capital sold out of Transmedics (TMDX) in Q3 2024, closing a stake of 16 shares — an estimated $2.41K sold.

Innealta Capital first reported a position in TMDX in Q2 2024 and held it in 1 quarter. The position peaked at $2.41K in Q2 2024. 373 funds tracked by Wall St. Rank hold TMDX as of Q3 2024.

Innealta Capital reported no remaining Transmedics position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 16 Transmedics shares in Q3 2024, an estimated $2.41K.
Innealta Capital first reported a position in Transmedics in Q2 2024 and held it in 1 quarter.
Innealta Capital's Transmedics position peaked at $2.41K in Q2 2024.
373 funds tracked by Wall St. Rank held Transmedics as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.